Company / Current Assets
Prime Medicine, Inc. Current Assets History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$211.9M
FY2024
5-year range
$143.0M / $296.6M
FY2021-FY2024
Trend
+48.2%
vs FY2023
Sector context
#181 of 214
Health Care
What the data says
Prime Medicine, Inc.'s current assets of $212M is lower than 85% of companies in the Health Care sector (FY2024). Declined from $297M to $212M over the past 2 years.
Based on SEC 10-K filings.
$212M in FY2024 with a 3-year CAGR of -7.8%.
Declined from $297M to $212M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 214This company $211.9M Sector average $2.5B
▼
-91.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -7.8%, indicating a declining trend.
- In FY2024, current assets increased 48.2% year-over-year.
- Ranks #181 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $211.9M | +48.2% |
| FY2023 | $143.0M | -51.8% |
| FY2022 | $296.6M | +9.6% |
| FY2021 | $270.6M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026